Dr. Claussnitzer is the Weissman Davis and Titlebaum Research Scholar and Associate Professor of Medicine at the Center for Genomic Medicine and the Endocrine Division at Massachusetts General Hospital, Harvard Medical School. She is an Institute Member at the Broad Institute of MIT and Harvard where she directs the Scientific Strategy of the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease and she is the Director of the Diabetes Initiative at the Broad Institute. Dr. Claussnitzer’s research focuses on traversing the path from metabolic disease genetics to disease-driving targets and biology (Variant-to-Function, V2F), by developing next-generation experimental and computational V2F strategies.
Dr. Claussnitzer holds a PhD in functional genomics from the Technical University of Munich followed by postdoctoral studies and (faculty) appointments at Harvard Medical School, the Computer Science and Artificial Intelligence Lab at Massachusetts Institute of Technology (MIT) and the Broad Institute of MIT and Harvard.
